Location History:
- Taipei, TW (2004 - 2014)
- New Taipei, TW (2023)
Company Filing History:
Years Active: 2004-2023
Title: Liahng-Yirn Liu: Innovator in Therapeutic Antibodies
Introduction
Liahng-Yirn Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Liu's work focuses on innovative solutions for cancer treatment and detection.
Latest Patents
Liu's latest patents include groundbreaking research on therapeutic antibodies. One of his notable inventions involves humanized antibodies and antigen-binding fragments that specifically target biantennary Lewis antigens, which are expressed in various cancers. These antibodies are designed to effectively target antigen-expressing cells, facilitating treatment and detection of diseases, including different types of cancer. Additionally, he has developed antibodies against extended Type I chain antigens, particularly extended Type I chain glycosphingolipids. These antibodies are crucial for diagnosing, treating, and preventing diseases associated with the improper activity or metabolism of these antigens.
Career Highlights
Throughout his career, Liu has worked with reputable organizations such as Glyconex, Inc. and the Development Center for Biotechnology. His experience in these companies has allowed him to advance his research and contribute to the field of biotechnology significantly.
Collaborations
Liu has collaborated with notable colleagues, including Tong-Hsuan Chang and Jerry Ting. These partnerships have further enriched his research and innovation in therapeutic antibodies.
Conclusion
Liahng-Yirn Liu's contributions to the field of biotechnology, particularly in therapeutic antibodies, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in cancer treatment and detection.